MedTrace Logo

Strength Training on Pancreatic Cancer

NCT01395563 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-03-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether prednisone, methotrexate, and cyclophosphamide are effective in the treatment of rapidly progressive hearing loss in both ears due to autoimmune inner ear disease (AIED).

Conditions

  • Pancreatic Neoplasms
  • Cachexia
  • Myopathy

Interventions

BEHAVIORAL

strength training

strength training, high intensity, twice up to 3 times per week

Sponsors & Collaborators

  • Heidelberg University

    collaborator OTHER

  • Technical University of Munich

    collaborator OTHER

  • German Cancer Research Center

    lead OTHER

Principal Investigators

  • Jens Werner, Prof. Dr. med. · Heidelberg University

  • Holger Krakowski-Roosen, Dr. · German CRC

  • Marc Martignoni, PD Dr. med. · Technical University of Munich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01395563 on ClinicalTrials.gov